Monday, October 18

US FDA approves ChemoCentryx drug to treat rare autoimmune disease

Article content

The US Food and Drug Administration on

Friday approved ChemoCentryx Inc’s lead drug candidate,

Avacopan, for treating a rare, fatal autoimmune disease, the

biopharmaceutical company said.

(Reporting by Oishee Majumdar and Dania Nadeem in Bengaluru;

Editing by Anil D’Silva)

Leave a Reply

Your email address will not be published. Required fields are marked *